|
2024
|
Invention
|
Methods and kits for diagnosing cause of nephrotic syndrome and guiding therapy. The present inve... |
|
|
G/S
|
Educational computer applications; Mobile apps; Application software for robot; Web application s... |
|
2023
|
Invention
|
Pyrazole derivatives for the treatment of cystic fibrosis.
The present invention relates to comp... |
|
2020
|
Invention
|
Use of esculentin and its derivatives for use in the treatment of cystic fibrosis. 22 and/or Escu... |
|
|
Invention
|
Use of esculentin and its derivatives for use in the treatment of cystic fibrosis. Are disclosed ... |
|
|
Invention
|
Compounds and compositions for the treatment of cystic fibrosis. The present invention relates to... |
|
|
Invention
|
3-[4-substituted sulfonylmorpholin-2-yl]benzothiophene-2-carboxamide compounds and use thereof fo... |
|
2018
|
Invention
|
Heterocyclic derivatives for the treatment of cystic fibrosis. The present invention relates to c... |
|
|
Invention
|
Pyrazole derivatives for the treatment of cystic fibrosis. The present invention relates to compo... |
|
2014
|
Invention
|
Method for assessing activity of an autoinflammatory disease.
The invention relates to a method ... |
|
|
Invention
|
Method for assessing activity of an autoinflammatory disease. The invention relates to a method f... |
|
2011
|
Invention
|
Lipid vectors delivering gene silencers.
Lipid vector delivering gene silencers which vector car... |
|
|
Invention
|
Lipid vectors delivering gene silencers. Lipid vector delivering gene silencers which vector carr... |
|
2007
|
Invention
|
Amphiphilic dextrin conjugates and their use in pharmaceutical formulations as complexing agents ... |
|
2004
|
Invention
|
Epitopes of the cytomegalovirus pp65 protein. Novel antigenic epitopes from Cytomegalovirus (CMV)... |
